1
Clinical Trials associated with Mannitol/ProlineA Phase I/II Crossover Study To Evaluate and Compare the Pharmacokinetics of a Single IV Dose of D-Mannitol (Osmitrol®10%) to Single and Multiple, Escalating Doses of Liquid, Oral Prodarsan™ in Patients With Cockayne Syndrome
This study is to compare the exposure of orally administered Prodarsan to the intravenous dosed Osmitrol (10% solution) in Cockayne Syndrome (CS) patients. Also the pharmacokinetics of single and multiple orally dosed Prodarsan will be evaluated and compared to intravenous dose of Osmitrol in CS patients.
100 Clinical Results associated with Mannitol/Proline
100 Translational Medicine associated with Mannitol/Proline
100 Patents (Medical) associated with Mannitol/Proline
1
News (Medical) associated with Mannitol/ProlineReuters -- Biotechnology company Pharming Group on Friday said the U.S. Food and Drug Administration accepted its investigational new drug application for Prodarsan, permitting a clinical trial to proceed.
100 Deals associated with Mannitol/Proline